Pernicious anemia has documented familial prevalence. First-degree relatives of PA patients carry a risk four times higher than the general population, and among siblings the figure is higher still — roughly six times the baseline rate. This reflects shared genetic architecture that shapes immune function across generations.
B12 deficiency more broadly also clusters in families through mechanisms that have nothing to do with autoimmunity — shared dietary patterns, shared variants in genes governing B12 metabolism and transport, and in rare cases inherited disorders of B12 absorption. A family history of B12 deficiency, even without a PA diagnosis, is relevant.
Contents
Autoimmune Inheritance
PA belongs to a group of autoimmune conditions that share underlying genetic susceptibility. The conditions most consistently associated with PA in families include autoimmune thyroid disease (both Hashimoto’s and Graves’), type 1 diabetes, vitiligo, rheumatoid arthritis, and Addison’s disease.
This clustering reflects shared immune dysregulation. The same inherited variants that predispose a person to PA create a permissive environment for autoimmunity more broadly. Having one autoimmune condition in a family raises the probability of others, and the susceptibility is often detectable — relatives frequently carry organ-specific autoantibodies years before any clinical diagnosis.
The Prenatal Layer
A mother with untreated or undertreated PA or B12 deficiency passes that environment to her child in utero. B12 transfer across the placenta depends on maternal levels — a deficient mother produces an infant with low hepatic stores from birth. If deficiency continues through lactation, breast milk provides insufficient B12 and the infant’s stores deplete rapidly, sometimes producing severe neurological symptoms within the first months of life.
For adults assessing their own risk: a family member with PA or B12 deficiency may represent both inherited autoimmune risk and a depleted biochemical baseline established before birth. These are additive factors, not alternative explanations.
Neurological Damage Is the Real Danger
Neurological and psychiatric symptoms frequently appear months or years before any blood abnormality. PA does not require anemia to cause serious damage, and a normal CBC provides no reassurance about neurological status.
The psychiatric presentation is well documented and routinely missed. Depression, anxiety, irritability, emotional instability, memory loss, brain fog, and personality changes can be the first and only visible signs of deficiency. Paranoia, delusions, and hallucinations occur in more severe cases. These presentations lead to psychiatric diagnoses while the underlying deficiency goes undetected and untreated. Up to 20-30% of patients with significant neurological B12 deficiency have no anemia and normal blood counts.
Demyelination — the breakdown of the myelin sheath protecting nerve fibers — can be permanent if deficiency continues untreated. Early signs include tingling or numbness in the hands and feet, burning sensations, balance problems, unsteady gait, and muscle weakness. Lhermitte’s sign — an electric shock sensation down the spine on neck flexion — is a specific marker worth knowing. Vision changes can occur. These symptoms reflect the same process that, at its most severe, produces subacute combined degeneration of the spinal cord.
The anemia, when it appears, is treatable and reversible. The neurological damage often is not.
Infants Born to Deficient Mothers
Infants born to mothers with untreated PA or significant B12 deficiency are at high risk and deteriorate rapidly — sometimes within two to four months of birth. The presentation is neurological and developmental: loss of acquired milestones, hypotonia, tremors, seizures, failure to thrive despite adequate feeding. Standard serum B12 testing misses many of these cases. If you have PA or a family history of B12 deficiency and are pregnant, recently delivered, or concerned about an infant or grandchild, the maternal guide covers this in detail. B12 Deficiency Across the Pregnancy Timeline (in progress)
Getting Properly Tested
A family history of PA, B12 deficiency, or related autoimmune conditions is clinical information. It belongs in every relevant medical conversation and should lower the threshold for proper testing.
Serum B12 alone is an unreliable screening tool. It misses functional deficiency, produces false negatives, and provides no information about neurological status. Functional markers — methylmalonic acid (MMA) and homocysteine — reflect what is actually happening at the cellular level and should be requested alongside serum B12. Intrinsic factor antibody testing is specific for PA; a positive result at any detectable level confirms the diagnosis, but the test has a false negative rate of 40-60% and a negative result does not rule it out.
Testing does not always produce a clear answer, and people with a family history are disproportionately likely to end up in diagnostic limbo — symptomatic enough to be concerned, not positive enough on labs to get a diagnosis or treatment. When testing is inconclusive, a therapeutic trial is the appropriate next step. B12 injections are administered for a defined period and symptoms are tracked. If symptoms improve, that is meaningful clinical information. The trial must use injections, not oral supplementation — passive absorption can raise serum B12 in PA patients independently of intrinsic factor, but serum levels do not reflect intracellular availability, and a response on paper is not a response in tissue.
A therapeutic trial is a legitimate and recognized clinical tool. If your doctor is unfamiliar with the diagnostic limitations or dismisses family history as a reason to test, the diagnosis and testing guide covers the full testing pathway and how to advocate for appropriate workup. Diagnosis and Testing Guide
A Note on these Guides
PA is frequently underdiagnosed, undertreated, and misunderstood. If you are here because of a family history, you are asking the right questions early. The guides in this group cover diagnosis, treatment, associated conditions, and how to navigate a medical system that often fails this patient population. A family history is not a diagnosis, but it is a reason to pay attention, advocate for proper testing, and not accept dismissal.
Children of PA families are also at risk. If PA or B12 deficiency runs in your family, that history is relevant for your children too — both as something to watch for as they grow and as information their doctors should have.
This is cross-posted as a group Guide at https://www.facebook.com/groups/anemia.facts